IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lifeward LTD (LFWD)

CUSIP: M8216Q309 | 11 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13DOramed Pharmaceuticals Inc.1,528,22149.9%New 5%+ stakeMar 25, 2026No 13F filer matched
13DOramed Pharmaceuticals Inc.1,528,221
49.9% of class · Mar 25, 2026

Institutional Holders — Q3 2026

UBS Group AG1,952
0.0% of portfolio›$12.9K
Citigroup Inc518
0.0% of portfolio›$3.4K
SBI Securities Co., Ltd.196
0.0% of portfolio›$1.3K
Caitong International Asset Management Co., Ltd7
0.0% of portfolio›$46
StyleTurnoverLocationFiled
UBS Group AG
1,952$12.9K0.0%CoreMediumZurich, Switzerland2026-11-10
Citigroup Inc
518$3.4K0.0%CoreMediumNew York, NY2026-11-04
SBI Securities Co., Ltd.
196$1.3K0.0%GrowthLowTokyo, Mexico2026-10-22
Caitong International Asset Management Co., Ltd
7$460.0%GrowthVery HighHong Kong, South Korea2026-10-29
New 5%+ stake
No 13F filer matched